Assembly Biosciences, Inc(NASDAQ:ASMB) 
Assembly Biosciences, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops oral therapeutic candidates for the treatment of hepatitis B virus (HBV) infection. Its product candidates include Vebicorvir to treat patients with chronic HBV infection; ABI-H21...
Website: http://www.assemblybio.com
Founded: 2005
Full Time Employees: 140
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 9.12
H 9.21
L 8.50
C 8.71
V 63,302
10EMA 8.71
20EMA 8.71
60EMA 8.71
120EMA 8.71
250EMA 8.71